Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Schuster

Showing results (311-320 of 371) with videos related to

Pageof 38
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 29, 1999
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study GroupR Zahn, S Schuster, R Schiele, et al.
Critical Care Medicine|September 18, 2020
Treatment and Mortality of Hemophagocytic Lymphohistiocytosis in Adult Critically Ill Patients: A Systematic Review With Pooled AnalysisCornelia Knaak, Friederike S Schuster, Peter Nyvlt, et al.
Critical Care (London, England)|May 26, 2020
Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScoreCornelia Knaak, Peter Nyvlt, Friederike S Schuster, et al.
Zeitschrift Fur Kardiologie|November 7, 1999
[Use of coronary angiography after acute myocardial infarction in Germany: a comparison of daily clinical practice with international guidelines. MITRA Study]S Schuster, A Koch, U Burczyk, et al.
Cell|October 24, 2017
ILC1 Confer Early Host Protection at Initial Sites of Viral InfectionOrr-El Weizman, Nicholas M Adams, Iona S Schuster, et al.
Scientific Reports|October 29, 2017
Ocular antigen does not cause disease unless presented in the context of inflammationValentina Voigt, Matthew E Wikstrom, Jelena M Kezic, et al.
The Journal of Clinical Investigation|November 1, 1980
Lung growth and airway function after lobectomy in infancy for congenital lobar emphysemaJ T McBride, M E Wohl, D J Strieder, et al.
Environmental Science & Technology|July 17, 2009
Overcoming nontechnical barriers to the implementation of sustainable solutions in industryM Barclay Satterfield, Charles E Kolb, Robert Peoples, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsBenjamin S Schuster, Anthony J Kim, Joshua C Kays, et al.
Nature Communications|August 26, 2025
Phosphorylation toggles the SARS-CoV-2 nucleocapsid protein between two membrane-associated condensate statesBruna Favetta, Huan Wang, Jasmine Cubuk, et al.
Pageof 38

Showing results (311-320 of 371) with videos related to

Sort By:
Pageof 38
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 29, 1999
Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study GroupR Zahn, S Schuster, R Schiele, et al.
Critical Care Medicine|September 18, 2020
Treatment and Mortality of Hemophagocytic Lymphohistiocytosis in Adult Critically Ill Patients: A Systematic Review With Pooled AnalysisCornelia Knaak, Friederike S Schuster, Peter Nyvlt, et al.
Critical Care (London, England)|May 26, 2020
Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScoreCornelia Knaak, Peter Nyvlt, Friederike S Schuster, et al.
Zeitschrift Fur Kardiologie|November 7, 1999
[Use of coronary angiography after acute myocardial infarction in Germany: a comparison of daily clinical practice with international guidelines. MITRA Study]S Schuster, A Koch, U Burczyk, et al.
Cell|October 24, 2017
ILC1 Confer Early Host Protection at Initial Sites of Viral InfectionOrr-El Weizman, Nicholas M Adams, Iona S Schuster, et al.
Scientific Reports|October 29, 2017
Ocular antigen does not cause disease unless presented in the context of inflammationValentina Voigt, Matthew E Wikstrom, Jelena M Kezic, et al.
The Journal of Clinical Investigation|November 1, 1980
Lung growth and airway function after lobectomy in infancy for congenital lobar emphysemaJ T McBride, M E Wohl, D J Strieder, et al.
Environmental Science & Technology|July 17, 2009
Overcoming nontechnical barriers to the implementation of sustainable solutions in industryM Barclay Satterfield, Charles E Kolb, Robert Peoples, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2014
Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectorsBenjamin S Schuster, Anthony J Kim, Joshua C Kays, et al.
Nature Communications|August 26, 2025
Phosphorylation toggles the SARS-CoV-2 nucleocapsid protein between two membrane-associated condensate statesBruna Favetta, Huan Wang, Jasmine Cubuk, et al.
Pageof 38